News
Ireland is an “outlier” in not opposing European Union reforms of the pharmaceutical industry that would potentially damage ...
Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...
As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.
The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...
Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...
The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...
In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...
Several major drugmakers are counting on their manufacturing flexibility to counter potential disruptions from tariffs ...
Potential US tariffs add urgency to the EU’s pharma regulation debate, balancing industry calls for innovation against ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.
The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results